Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Reducing body myopathy--a case report].

Y Kobayashi1, K Nihei, K Kuwajima

  • 1Department of Pediatrics, Jichi Medical School.

Rinsho Shinkeigaku = Clinical Neurology
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhanced immunity in intradermal vaccination by novel hollow microneedles.

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)·2018
Same author

Cloning and mapping of a very short (10-kb) EcoRI fragment associated with facioscapulohumeral muscular dystrophy (FSHD).

Muscle & nerve. Supplement·2013
Same author

Inflammatory response in facioscapulohumeral muscular dystrophy (FSHD): immunocytochemical and genetic analyses.

Muscle & nerve. Supplement·2013
Same author

Characterization of the Asian myopathy patients with VCP mutations.

European journal of neurology·2011
Same author

Difference in the nature of tannins on in vitro ruminal methane and volatile fatty acid production and on methanogenic archaea and protozoal populations.

Journal of dairy science·2009
Same author

Novel FHL1 mutations in fatal and benign reducing body myopathy.

Neurology·2009
Same journal

[Utility of acute-phase cerebral blood flow single photon emission computed tomography (SPECT) for evaluating the pathophysiology of Bickerstaff brainstem encephalitis with decorticate posturing].

Rinsho shinkeigaku = Clinical neurology·2026
Same journal

[Successful treatment with rituximab in unilateral relapsing primary CNS vasculitis: a ‍case report].

Rinsho shinkeigaku = Clinical neurology·2026
Same journal

[Clinical management of headache comorbid with functional neurological disorder].

Rinsho shinkeigaku = Clinical neurology·2026
Same journal

[Transient myoclonic state with asterixis related to COVID-19].

Rinsho shinkeigaku = Clinical neurology·2026
Same journal

[Let's present at a regional meeting].

Rinsho shinkeigaku = Clinical neurology·2026
Same journal

[Editor's Note].

Rinsho shinkeigaku = Clinical neurology·2026
See all related articles

A 2-year-old girl developed rapidly progressive myopathy after mumps vaccination, characterized by reducing bodies in muscle fibers. This case highlights a potential link between vaccination and the onset of this rare neuromuscular disorder.

Area of Science:

  • Neuromuscular Disorders
  • Pediatric Neurology
  • Muscle Pathology

Background:

  • Reducing body myopathy is a rare neuromuscular disorder.
  • Typically presents in childhood with progressive muscle weakness.
  • Etiology and pathogenesis remain largely unknown.

Observation:

  • A 2-year-old girl presented with acute onset of generalized muscle weakness following mumps vaccination.
  • Clinical examination revealed proximal dominant weakness, neck muscle involvement, and waddling gait.
  • Electromyography showed a myopathic pattern and elevated creatine kinase levels.

Findings:

  • Muscle biopsy demonstrated characteristic "reducing" bodies, identified by histochemical staining and electron microscopy.
  • These bodies were eosinophilic inclusions associated with disorganized muscle fiber networks and nuclear degeneration.

Related Experiment Videos

  • Reducing bodies stained dark with menadione-linked alpha-glycerophosphate dehydrogenase, indicating their unique biochemical properties.

    • Implications:

    • This case suggests a potential association between vaccination and the onset of reducing body myopathy.
    • Further research is needed to elucidate the role of nuclear degeneration in the formation of reducing bodies.
    • Understanding the pathogenesis may lead to improved diagnostic and therapeutic strategies for this rare myopathy.